Moreover, in one study, an engineered long-acting recombinant GDF15 protein was shown to exert a strong weight-lowering effect in obese mice and monkeys (337), confirming its potential application for treating obesity and associated metabolic disorders. This evidence concerns the gene GDF15 and metabolic disease.